STME (Stimcell Energetics) Net Margin %: 0.00% (As of Feb. 2026)


STME Stimcell Energetics Inc STME
25 GF Score
Price $0.35
! 4 Warning Signs
View Full Analysis

What is Stimcell Energetics Net Margin %?

Stimcell Energetics STME +0.57% 25 Net Margin % is 0.00% as of Feb. 2026. GuruFocus rates STME with a GF Score™ of 25/100. The stock has 4 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Stimcell Energetics ranks worse than 122398.9% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Stimcell Energetics's Net Income for the three months ended in Feb. 2026 was $-0.09 Mil. Stimcell Energetics's Revenue for the three months ended in Feb. 2026 was $0.00 Mil. Therefore, Stimcell Energetics's net margin for the quarter that ended in Feb. 2026 was 0.00%.

The historical rank and industry rank for Stimcell Energetics's Net Margin % or its related term are showing as below:


STME's Net Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.07
* Ranked among companies with meaningful Net Margin % only.

Stimcell Energetics  (OTCPK:STME) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Stimcell Energetics Net Margin % Related Terms

Stimcell Energetics Net Margin % Historical Data

* Premium members only.

The historical data trend for Stimcell Energetics's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stimcell Energetics Net Margin % Chart

Stimcell Energetics Annual Data
Trend May16 May17 May18 May19 May20 May21 May22 May23 May24 May25
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -13,014.29 -11,616.67 -16,500.00 0.00 0.00

Stimcell Energetics Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

STME vs BMRA, NVNO, TNON: Net Margin % Comparison

For the Medical Devices subindustry, Stimcell Energetics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stimcell Energetics Net Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stimcell Energetics's Net Margin % distribution charts can be found below:

* The bar in red indicates where Stimcell Energetics's Net Margin % falls into.


STME
25GF Score
Stimcell Energetics Inc STME
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Stimcell Energetics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Stimcell Energetics's Net Margin for the fiscal year that ended in May. 2025 is calculated as

Net Margin=Net Income (A: May. 2025 )/Revenue (A: May. 2025 )
=-0.566/0
= %

Stimcell Energetics's Net Margin for the quarter that ended in Feb. 2026 is calculated as

Net Margin=Net Income (Q: Feb. 2026 )/Revenue (Q: Feb. 2026 )
=-0.091/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Stimcell Energetics (STME) has a Net Margin % of 0.00% as of Feb. 2026. Net margin is the ratio of total net income to net sales. View historical data on Stimcell Energetics and its competitors. According to the industry distribution chart, Stimcell Energetics ranks #999999 out of 817 companies in the Medical Devices & Instruments industry.
Is Stimcell Energetics' Net Margin % too high?
Stimcell Energetics' current Net Margin % is 0.00%. Based on the distribution chart, Stimcell Energetics ranks #999999 out of 817 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Stimcell Energetics has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Stimcell Energetics' Net Margin % compare to BMRA and NVNO?
According to the Medical Devices & Instruments industry distribution chart, Stimcell Energetics ranks #999999 out of 817 companies for Net Margin %. This places Stimcell Energetics in the lower half of its industry. The industry median Net Margin % is 2.07. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.07, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Stimcell Energetics and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Stimcell Energetics's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stimcell Energetics stock overvalued right now?
Stimcell Energetics (STME) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Stimcell Energetics' overall GF Score™ is 25/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Stimcell Energetics (STME), the current Net Margin % is 0.00% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Stimcell Energetics Business Description

Address 1130 Pender Street, West, Suite 820, Vancouver, BC, CAN, V6E 4A4
Stimcell Energetics Inc is a biotech company focused on the discovery, development, and commercialization of therapeutic and non-therapeutic products that enhance cellular function, promote general wellness, and alleviate health complications, including, but not limited to: aging, diabetes, high blood pressure, neuropathy, and kidney function. The company's main focus is on continued research and development of its eBalance Technology and its eBalance Home System.
25GF Score

Get the complete analysis for STME

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.35
Price